| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 89, 224-227, Copyright © 1994 by American Heart Association
RL Page, WE Wilkinson, WK Clair, EA McCarthy and EL Pritchett
BACKGROUND: Paroxysmal atrial fibrillation and paroxysmal supraventricular
tachycardia are recognized clinically when patients seek treatment for
symptoms due to recurrent arrhythmias; atrial fibrillation also increases
the risk of stroke. The frequency with which asymptomatic arrhythmias occur
in patients with these arrhythmias is unknown. METHODS AND RESULTS:
Twenty-two patients with paroxysmal atrial fibrillation (n = 8) or
paroxysmal supraventricular tachycardia (n = 14) were studied for 29 days
with two different ambulatory ECG- monitoring techniques to measure the
relative frequency of asymptomatic and symptomatic arrhythmias. All class I
antiarrhythmic drugs, calcium channel blockers, beta-blockers, and
digitalis were withheld. Sustained asymptomatic arrhythmia events (defined
as lasting at least 30 seconds) were documented using continuous ambulatory
ECG monitoring once weekly for a total of 5 of the 29 study days;
symptomatic arrhythmia events were documented using transtelephonic ECG
monitoring for all 29 days of the study. In the group of patients with
paroxysmal atrial fibrillation, asymptomatic arrhythmia events occurred
significantly more frequently than symptomatic arrhythmia events; the mean
rates, expressed as events/100 d/patient (95% confidence interval), were
62.5 (40.4, 87.3) and 5.2 (2.7, 9.0) (P < .01); the ratio of the mean
rates was 12.1 (5.8, 26.4). In contrast, in the group of patients with
paroxysmal supraventricular tachycardia, asymptomatic arrhythmia events
were significantly less frequent than symptomatic arrhythmia events; the
mean rates were 0.0 (0.0, 5.3) and 7.4 (5.0, 10.6) (P = .02). The ratio of
the mean rates was 0.0 (0.0, 0.8). CONCLUSIONS: In a group of patients with
paroxysmal atrial fibrillation, sustained asymptomatic atrial fibrillation
occurs far more frequently than symptomatic atrial fibrillation. However,
it is not known whether asymptomatic atrial fibrillation is a potential
risk factor for stroke even when patients are not having symptomatic
arrhythmias.
ARTICLES
Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia
Department of Medicine, Duke University Medical Center, Durham, NC.
This article has been cited by other articles:
![]() |
G. Kaleschke, B. Hoffmann, I. Drewitz, G. Steinbeck, M. Naebauer, A. Goette, G. Breithardt, and P. Kirchhof Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes Europace, October 1, 2009; 11(10): 1362 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Halimi, L. Van Erven, and on behalf of the EHRA Scientific Initiatives Commi Validation of success following atrial fibrillation ablation: a European survey Europace, August 1, 2009; 11(8): 1002 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al. Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation' Europace, July 1, 2009; 11(7): 860 - 885. [Full Text] [PDF] |
||||
![]() |
M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies Mayo Clin. Proc., July 1, 2009; 84(7): 643 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. John Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF' Eur. Heart J., June 17, 2009; (2009) ehp235v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dorian, P. G. Guerra, C. R. Kerr, S. S. O'Donnell, E. Crystal, A. M. Gillis, L. B. Mitchell, D. Roy, A. C. Skanes, M. S. Rose, et al. Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale Circ Arrhythm Electrophysiol, June 1, 2009; 2(3): 218 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arya, J. Silberbauer, S. L. Teichman, P. Milner, N. Sulke, and A. J. Camm A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology Europace, April 1, 2009; 11(4): 458 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kaireviciute, A. Aidietis, and G. Y.H. Lip Atrial fibrillation following cardiac surgery: clinical features and preventative strategies Eur. Heart J., February 2, 2009; 30(4): 410 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Camm and J. A. Reiffel Defining endpoints in clinical trials on atrial fibrillation Eur. Heart J. Suppl., September 1, 2008; 10(suppl_H): H55 - H78. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 546S - 592S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Nguyen and D. G. Benditt Atrial Fibrillation Susceptibility in Metabolic Syndrome: Simply the Sum of Its Parts? Circulation, March 11, 2008; 117(10): 1249 - 1251. [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al. Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA) Eur. Heart J., November 2, 2007; 28(22): 2803 - 2817. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al. Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association Europace, November 1, 2007; 9(11): 1006 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. de Voogt, N. van Hemel, P. de Vusser, G. H. Mairesse, R. van Mechelen, J. Koistinen, A. van den Bos, I. Roose, J. Voitk, S. Yli-Mayry, et al. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation Europace, September 1, 2007; 9(9): 798 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Mehall, R. M. Kohut Jr, E. W. Schneeberger, W. H. Merrill, and R. K. Wolf Absence of Correlation Between Symptoms and Rhythm in "Symptomatic" Atrial Fibrillation Ann. Thorac. Surg., June 1, 2007; 83(6): 2118 - 2121. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F Murphy, C. R Simpson, P. S Jhund, S. Stewart, M. Kirkpatrick, J. Chalmers, K. MacIntyre, and J. J V McMurray A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland Heart, May 1, 2007; 93(5): 606 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Sherman Stroke Prevention in Atrial Fibrillation: Pharmacological Rate Versus Rhythm Control Stroke, February 1, 2007; 38(2): 615 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. van der Kooi, W. G. de Voogt, E. Bertini, L. Merlini, F. B. Talim, R. Ben Yaou, A. Urtziberea, and M. de Visser Cardiac and Pulmonary Investigations in Bethlem Myopathy Arch Neurol, November 1, 2006; 63(11): 1617 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF] |
||||
![]() |
A Nergardh and M Frick Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation Heart, September 1, 2006; 92(9): 1244 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
T R Betts Rhythm control strategies for "symptomatic" persistent atrial fibrillation: is achieving sinus rhythm enough? Heart, September 1, 2006; 92(9): 1189 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): 700 - 752. [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030. [Full Text] [PDF] |
||||
![]() |
T. Neumann, A. Erdogan, T. Dill, H. Greiss, A. Berkowitsch, J. Sperzel, M. Kuniss, K. Kurzidim, C. W. Hamm, and H.-F. Pitschner Asymptomatic recurrences of atrial fibrillation after pulmonary vein isolation Europace, July 1, 2006; 8(7): 495 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hoffmann, N. Sulke, N. Edvardsson, J. Ruiter, T. Lewalter, A. Capucci, A. Schuchert, S. Janko, J. Camm, and on behalf of the Atrial Fibrillation Therapy (AFT) New Insights Into the Initiation of Atrial Fibrillation: A Detailed Intraindividual and Interindividual Analysis of the Spontaneous Onset of Atrial Fibrillation Using New Diagnostic Pacemaker Features Circulation, April 25, 2006; 113(16): 1933 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Enseleit and F. Duru Long-term continuous external electrocardiographic recording: a review. Europace, April 1, 2006; 8(4): 255 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hindricks, C. Piorkowski, H. Tanner, R. Kobza, J.-H. Gerds-Li, C. Carbucicchio, and H. Kottkamp Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence Circulation, July 19, 2005; 112(3): 307 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Sherman, S. G. Kim, B. S. Boop, S. D. Corley, J. P. DiMarco, R. G. Hart, L. J. Haywood, K. Hoyte, E. S. Kaufman, M. H. Kim, et al. Occurrence and Characteristics of Stroke Events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study Arch Intern Med, May 23, 2005; 165(10): 1185 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Gersh, T. S.M. Tsang, M. E. Barnes, and J. B. Seward The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C5 - C11. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Bajaj and S. D. Hillson Obesity and the Risk of New-Onset Atrial Fibrillation JAMA, April 27, 2005; 293(16): 1974 - 1975. [Full Text] [PDF] |
||||
![]() |
G. C. Gronefeld, S. H. Hohnloser, S. H. Konety, B. Olshansky, A. K. Wittkowsky, P. Alboni, G. I. Botto, and N. Baldi The "Pill-in-the-Pocket" Approach to Atrial Fibrillation N. Engl. J. Med., March 17, 2005; 352(11): 1150 - 1151. [Full Text] [PDF] |
||||
![]() |
P. D. Bella, S. Riva, G. Fassini, M. Casella, C. Carbucicchio, N. Trevisi, M. Berti, F. Giraldi, and G. Maccabelli Long-term follow-up after radiofrequency catheter ablation of atrial fibrillation: Role of the acute procedure outcome and of the clinical presentation Europace, January 1, 2005; 7(2): 95 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Page Newly Diagnosed Atrial Fibrillation N. Engl. J. Med., December 2, 2004; 351(23): 2408 - 2416. [Full Text] [PDF] |
||||
![]() |
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 429S - 456S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. van Hemel Quinidine rehabilitated and more lessons from the PAFAC and SOPAT anti-arrhythmic drug trials for the prevention of paroxysmal atrial fibrillation Eur. Heart J., August 2, 2004; 25(16): 1371 - 1373. [Full Text] [PDF] |
||||
![]() |
T. Fetsch, P. Bauer, R. Engberding, H. P. Koch, J. Lukl, T. Meinertz, M. Oeff, L. Seipel, H. J. Trappe, N. Treese, et al. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial Eur. Heart J., August 2, 2004; 25(16): 1385 - 1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ballo, D. Bernabo, and S. A. Faraguti Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia Eur. Heart J., August 1, 2004; 25(15): 1310 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Kaufman and A. L. Waldo The impact of asymptomatic atrial fibrillation J. Am. Coll. Cardiol., January 7, 2004; 43(1): 53 - 54. [Full Text] [PDF] |
||||
![]() |
L. Kristensen, J. C. Nielsen, P. T. Mortensen, A. K. Pedersen, and H. R. Andersen Evaluation of pacemaker telemetry as a diagnostic feature for detecting atrial tachyarrhythmias in patients with sick sinus syndrome Europace, January 1, 2004; 6(6): 580 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R Kasliwal, S. Mukesh, G. Manohar, N. Aggarwal, and A. Bhatia Pharmacotherapy of Atrial Fibrillation Asian Cardiovasc Thorac Ann, December 1, 2003; 11(4): 364 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Singer A 60-Year-Old Woman With Atrial Fibrillation JAMA, October 22, 2003; 290(16): 2182 - 2189. [Full Text] [PDF] |
||||
![]() |
K. A. Ellenbogen and M. A. Wood Ablation of atrial fibrillation: awaiting the new paradigm J. Am. Coll. Cardiol., July 16, 2003; 42(2): 198 - 200. [Full Text] [PDF] |
||||
![]() |
D. Darbar, K. J. Herron, J. D. Ballew, A. Jahangir, B. J. Gersh, W.-K. Shen, S. C. Hammill, D. L. Packer, and T. M. Olson Familial atrial fibrillation is a genetically heterogeneous disorder J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2185 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takami, M. Suzuki, K. Sugi, and T. Ikeda Time course for resolution of left atrial appendage stunning after catheter ablation of chronic atrial flutter J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2207 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V. Glotzer, A. S. Hellkamp, J. Zimmerman, M. O. Sweeney, R. Yee, R. Marinchak, J. Cook, A. Paraschos, J. Love, G. Radoslovich, et al. Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) Circulation, April 1, 2003; 107(12): 1614 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Page, T. W. Tilsch, S. J. Connolly, D. J. Schnell, S. R. Marcello, W. E. Wilkinson, E. L.C. Pritchett, and for the Azimilide Supraventricular Arrhythmia Prog Asymptomatic or "Silent" Atrial Fibrillation: Frequency in Untreated Patients and Patients Receiving Azimilide Circulation, March 4, 2003; 107(8): 1141 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Falk Management of Atrial Fibrillation -- Radical Reform or Modest Modification? N. Engl. J. Med., December 5, 2002; 347(23): 1883 - 1884. [Full Text] [PDF] |
||||
![]() |
G.Y.H. Lip and F.L. L. S. Hee Paroxysmal atrial fibrillation QJM, December 1, 2001; 94(12): 665 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Sparks and J. M. Kalman Is atrial flutter a risk factor for stroke? J. Am. Coll. Cardiol., September 1, 2001; 38(3): 785 - 788. [Full Text] [PDF] |
||||
![]() |
A. S. Go, E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, and D. E. Singer Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study JAMA, May 9, 2001; 285(18): 2370 - 2375. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Falk Atrial Fibrillation N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078. [Full Text] [PDF] |
||||
![]() |
S. S. Chugh, J. L. Blackshear, W.-K. Shen, S. C. Hammill, and B. J. Gersh Epidemiology and natural history of atrial fibrillation: clinical implications J. Am. Coll. Cardiol., February 1, 2001; 37(2): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Page, J. A. Reiffel, and M. E. Tavel Asymptomatic Atrial Fibrillation : Problems of Management Chest, February 1, 2001; 119(2): 628 - 631. [Full Text] [PDF] |
||||
![]() |
K. J. Ward, J. E. Willett, C. Bucknall, J. S. Gill, and K. Kamalvand Atrial arrhythmia suppression by atrial overdrive pacing: pacemaker Holter assessment Europace, January 1, 2001; 3(2): 108 - 114. [Abstract] [PDF] |
||||
![]() |
E. L. C. Pritchett, R. L. Page, S. J. Connolly, S. R. Marcello, D. J. Schnell, W. E. Wilkinson, and the Azimilide Supraventricular Arrhythmia Program Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response J. Am. Coll. Cardiol., September 1, 2000; 36(3): 794 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kuhlkamp, A. Schirdewan, K. Stangl, M. Homberg, M. Ploch, and O. A. Beck Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: A randomized, double-blind, placebo-controlled study J. Am. Coll. Cardiol., July 1, 2000; 36(1): 139 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Page Beta-blockers for atrial fibrillation: must we consider asymptomatic arrhythmias? J. Am. Coll. Cardiol., July 1, 2000; 36(1): 147 - 150. [Full Text] [PDF] |
||||
![]() |
A. De Sisti, P. Attuel, S. Manot, P. Fiorello, F. Halimi, and J.-F. Leclercq Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing Europace, January 1, 2000; 2(4): 304 - 311. [Abstract] [PDF] |
||||
![]() |
G.Y.H. Lip Atrial fibrillation and mortality Eur. Heart J., November 1, 1999; 20(21): 1525 - 1527. [PDF] |
||||
![]() |
S Viskin, M Golovner, N Malov, R Fish, I Alroy, Y Vila, S Laniado, E Kaplinsky, and A Roth Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10000 episodes Eur. Heart J., October 1, 1999; 20(19): 1429 - 1434. [Abstract] [PDF] |
||||
![]() |
M. H. Crawford, S. J. Bernstein, P. C. Deedwania, J. P. DiMarco, K. J. Ferrick, A. Garson Jr, L. A. Green, H. L. Greene, M. J. Silka, P. H. Stone, et al. ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology J. Am. Coll. Cardiol., September 1, 1999; 34(3): 912 - 948. [Full Text] [PDF] |
||||
![]() |
S. Levy, M. Maarek, P. Coumel, L. Guize, J. Lekieffre, J.-L. Medvedowsky, and A. Sebaoun Characterization of Different Subsets of Atrial Fibrillation in General Practice in France : The ALFA Study Circulation, June 15, 1999; 99(23): 3028 - 3035. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Murgatroyd, S. M. Gibson, X. Baiyan, S. O'Nunain, J. D. Poloniecki, D. E. Ward, M. Malik, and A. J. Camm Double-Blind Placebo-Controlled Trial of Digoxin in Symptomatic Paroxysmal Atrial Fibrillation Circulation, June 1, 1999; 99(21): 2765 - 2770. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Zimetbaum and M. E. Josephson The Evolving Role of Ambulatory Arrhythmia Monitoring in General Clinical Practice Ann Intern Med, May 18, 1999; 130(10): 848 - 856. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Anselme, N. Saoudi, H. Poty, R. Douillet, and A. Cribier Radiofrequency Catheter Ablation of Common Atrial Flutter : Significance of Palpitations and Quality-of-Life Evaluation in Patients With Proven Isthmus Block Circulation, February 2, 1999; 99(4): 534 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.A. Goudevenos, J.N. Vakalis, V. Giogiakas, P. Lathridou, C. Katsouras, L.K. Michalis, and D.A. Sideris An epidemiological study of symptomatic paroxysmal atrial fibrillation in northwest Greece Europace, January 1, 1999; 1(4): 226 - 233. [Abstract] [PDF] |
||||
![]() |
M. Rosenqvist, T. Beyer, M. Block, K. den Dulk, J. Minten, and F. Lindemans Adverse Events With Transvenous Implantable Cardioverter-Defibrillators : A Prospective Multicenter Study Circulation, August 18, 1998; 98(7): 663 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Paydak, J. G. Kall, M. C. Burke, D. Rubenstein, D. E. Kopp, R. J. Verdino, and D. J. Wilber Atrial Fibrillation After Radiofrequency Ablation of Type I Atrial Flutter : Time to Onset, Determinants, and Clinical Course Circulation, July 28, 1998; 98(4): 315 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Psaty, T. A. Manolio, L. H. Kuller, R. A. Kronmal, M. Cushman, L. P. Fried, R. White, C. D. Furberg, and P. M. Rautaharju Incidence of and Risk Factors for Atrial Fibrillation in Older Adults Circulation, October 7, 1997; 96(7): 2455 - 2461. [Abstract] [Full Text] |
||||
![]() |
L. B. Goldstein, A. Farmer, and D. B. Matchar Primary Care Physician–Reported Secondary and Tertiary Stroke Prevention Practices : A Comparison Between the United States and the United Kingdom Stroke, April 1, 1997; 28(4): 746 - 751. [Abstract] [Full Text] |
||||
![]() |
E. N. Prystowsky, D. W. Benson Jr, V. Fuster, R. G. Hart, G. N. Kay, R. J. Myerburg, G. V. Naccarelli, and D. G. Wyse Management of Patients With Atrial Fibrillation : A Statement for Healthcare Professionals From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association Circulation, March 15, 1996; 93(6): 1262 - 1277. [Full Text] |
||||
![]() |
A. P. Aboaf and P. S. Wolf Paroxysmal Atrial Fibrillation: A Common but Neglected Entity Arch Intern Med, February 26, 1996; 156(4): 362 - 367. [Abstract] [PDF] |
||||
![]() |
F. Philippon, V. J. Plumb, A. E. Epstein, and G. N. Kay The Risk of Atrial Fibrillation Following Radiofrequency Catheter Ablation of Atrial Flutter Circulation, August 1, 1995; 92(3): 430 - 435. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |